Karin Jooss, Ph.D.
Board Member
Fate Therapeutics Inc (FATE)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Karin Jooss, Ph.D.
Karin Jooss, Ph.D. is recorded as Board Member at Fate Therapeutics Inc (FATE). Fate Therapeutics Inc reported in an 8-K filed June 15, 2026 that Karin Jooss, Ph.D. was appointed Class I Director, effective June 12, 2026.
“The election of three Class I Directors, as nominated by the board of directors (the "Board") of the Company, to hold office until the 2029 Annual Meeting of Stockholders or until their successors are duly elected and qualified”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-06-12–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Fate Therapeutics Inc
Other people whose current roles at this company are on record from its filings.
- Bahram Valamehr CEO, Board Member
- Scott Wolchko CEO, Board Member
- William H. Rastetter Chairman
- J. Scott Wolchko CFO, Chief Accounting Officer
- Kamal Adawi CFO, Chief Accounting Officer
- Cindy R. Tahl General Counsel
- Edward J. Dulac III Chief Accounting Officer
- Karin Jooss Board Member
- Laura J. Hamill Board Member
- Matthew Abernethy Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.